Blade Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Blade Therapeutics's estimated annual revenue is currently $6M per year.(i)
  • Blade Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Blade Therapeutics has 39 Employees.(i)
  • Blade Therapeutics grew their employee count by -13% last year.

Blade Therapeutics's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Head Human ResourcesReveal Email/Phone
3
SVP Investor RelationsReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Managing DirectorReveal Email/Phone
6
EVP- Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Blade Therapeutics?

Blade Therapeutics is a private biopharmaceutical company founded on a commitment to revolutionize the treatment of debilitating, incurable fibrotic diseases that impact millions of people worldwide. The Company is an expert in novel biological pathways – including autotaxin / LPA and calpain biology – that are foundational to cell and tissue damage responses leading to fibrosis. We are advancing a robust pipeline of potential first- and best-in-class investigational therapies for diseases of lung, liver and heart fibrosis, as well as neuro-degenerative diseases. This includes multiple small-molecule direct inhibitors of autotaxin / LPA and dimeric calpains that offer distinct but complementary anti-fibrotic mechanisms. Since its founding in 2015, Blade has raised approximately $90 million, including investments from Deerfield Management, MPM Capital, Pfizer Ventures, One Ventures, Osage University Partners and pharma strategic investments from Bristol-Myers Squibb and Novartis Institutes for Biomedical Research. The Company has assembled critical leadership expertise supplemented by a world-class network of scientific, pharmaceutical and clinical advisors to enable efficient and successful drug development.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$6M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Blade Therapeutics News

2022-03-30 - Blade Therapeutics Announces Feedback from FDA on End-of ...

Blade Therapeutics, Inc. is a biopharmaceutical company focused on developing cutting-edge treatments for debilitating, incurable fibrotic and...

2022-03-22 - Blade Therapeutics to Present Data from Preclinical and ...

Blade Therapeutics, Inc. is a biopharmaceutical company focused on developing cutting-edge treatments for debilitating, incurable fibrotic and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M39-15%N/A
#2
$8.4M39-64%N/A
#3
$9.8M393%$86M
#4
$5.4M405%$44.7M
#5
$8M41-25%N/A